ERVW-1 and hepatocellular carcinoma: Additionally, it inhibits doxorubicin-induced apoptosis through the MEK/ERK cascade, indicating that syncytin-1 not only drives the progression of HCC but also contributes to the resistance to doxorubicin [31].